-
1
-
-
49749121806
-
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis
-
Kuenz B, Lutterotti A, Ehling R,. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 2008; 3: e2559.
-
(2008)
PLoS One
, vol.3
, pp. e2559
-
-
Kuenz, B.1
Lutterotti, A.2
Ehling, R.3
-
4
-
-
41849116363
-
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase i trial
-
Bar-Or A, Calabresi PA, Arnold D,. Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial. Ann Neurol 2008; 63: 395-400.
-
(2008)
Ann Neurol
, vol.63
, pp. 395-400
-
-
Bar-Or, A.1
Calabresi, P.A.2
Arnold, D.3
-
5
-
-
39049142995
-
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
-
Hauser SL, Waubant E, Arnold DL,. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008; 358: 676-688.
-
(2008)
N Engl J Med
, vol.358
, pp. 676-688
-
-
Hauser, S.L.1
Waubant, E.2
Arnold, D.L.3
-
6
-
-
81555202418
-
Ocrelizumab in relapsing-remitting multiple sclerosis: A phase 2, randomised, placebo-controlled, multicentre trial
-
Kappos L, Li D, Calabresi PA,. Ocrelizumab in relapsing-remitting multiple sclerosis: A phase 2, randomised, placebo-controlled, multicentre trial. Lancet 2011; 378: 1779-1787.
-
(2011)
Lancet
, vol.378
, pp. 1779-1787
-
-
Kappos, L.1
Li, D.2
Calabresi, P.A.3
-
7
-
-
77953335494
-
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
-
Naismith RT, Piccio L, Lyons JA,. Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial. Neurology 2010; 74: 1860-1867.
-
(2010)
Neurology
, vol.74
, pp. 1860-1867
-
-
Naismith, R.T.1
Piccio, L.2
Lyons, J.A.3
-
8
-
-
77951757865
-
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
-
Bar-Or A, Fawaz L, Fan B,. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol 2010; 67: 452-461.
-
(2010)
Ann Neurol
, vol.67
, pp. 452-461
-
-
Bar-Or, A.1
Fawaz, L.2
Fan, B.3
-
9
-
-
77957164949
-
IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro
-
Bouaziz JD, Calbo S, Maho-Vaillant M,. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010; 40: 2686-2691.
-
(2010)
Eur J Immunol
, vol.40
, pp. 2686-2691
-
-
Bouaziz, J.D.1
Calbo, S.2
Maho-Vaillant, M.3
-
10
-
-
0000324490
-
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines
-
Thompson CB, Lindsten T, Ledbetter JA,. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci U S A 1989; 86: 1333-1337.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 1333-1337
-
-
Thompson, C.B.1
Lindsten, T.2
Ledbetter, J.A.3
-
12
-
-
77957126531
-
Memory B cells from a subset of treatment-naive relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-gamma production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
-
Harp CT, Ireland S, Davis LS,. Memory B cells from a subset of treatment-naive relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-gamma production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur J Immunol 2010; 40: 2942-2956.
-
(2010)
Eur J Immunol
, vol.40
, pp. 2942-2956
-
-
Harp, C.T.1
Ireland, S.2
Davis, L.S.3
-
13
-
-
60549092755
-
Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells
-
Good KL, Avery DT, Tangye SG., Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 2009; 182: 890-901.
-
(2009)
J Immunol
, vol.182
, pp. 890-901
-
-
Good, K.L.1
Avery, D.T.2
Tangye, S.G.3
-
14
-
-
0035889871
-
Immunological memory: Contribution of memory B cells expressing costimulatory molecules in the resting state
-
Bar-Or A, Oliveira EM, Anderson DE,. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J Immunol 2001; 167: 5669-5677.
-
(2001)
J Immunol
, vol.167
, pp. 5669-5677
-
-
Bar-Or, A.1
Oliveira, E.M.2
Anderson, D.E.3
-
15
-
-
0030973198
-
Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy
-
Genc K, Dona DL, Reder AT., Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J Clin Invest 1997; 99: 2664-2671.
-
(1997)
J Clin Invest
, vol.99
, pp. 2664-2671
-
-
Genc, K.1
Dona, D.L.2
Reder, A.T.3
-
16
-
-
77955902024
-
The widespread regulation of microRNA biogenesis, function and decay
-
Krol J, Loedige I, Filipowicz W., The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
-
(2010)
Nat Rev Genet
, vol.11
, pp. 597-610
-
-
Krol, J.1
Loedige, I.2
Filipowicz, W.3
-
17
-
-
0347444723
-
MicroRNAs: Genomics, biogenesis, mechanism, and function
-
Bartel DP., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
-
(2004)
Cell
, vol.116
, pp. 281-297
-
-
Bartel, D.P.1
-
18
-
-
75649139134
-
Physiological and pathological roles for microRNAs in the immune system
-
OConnell RM, Rao DS, Chaudhuri AA,. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122.
-
(2010)
Nat Rev Immunol
, vol.10
, pp. 111-122
-
-
OConnell, R.M.1
Rao, D.S.2
Chaudhuri, A.A.3
-
19
-
-
39749101294
-
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage
-
Koralov SB, Muljo SA, Galler GR,. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860-874.
-
(2008)
Cell
, vol.132
, pp. 860-874
-
-
Koralov, S.B.1
Muljo, S.A.2
Galler, G.R.3
-
20
-
-
78650196925
-
MicroRNAs prevent the generation of autoreactive antibodies
-
Belver L, de Yebenes VG, Ramiro AR., MicroRNAs prevent the generation of autoreactive antibodies. Immunity 2010; 33: 713-722.
-
(2010)
Immunity
, vol.33
, pp. 713-722
-
-
Belver, L.1
De Yebenes, V.G.2
Ramiro, A.R.3
-
21
-
-
79952501096
-
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
-
Polman CH, Reingold SC, Banwell B,. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
-
(2011)
Ann Neurol
, vol.69
, pp. 292-302
-
-
Polman, C.H.1
Reingold, S.C.2
Banwell, B.3
-
22
-
-
0034727059
-
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group
-
Jacobs LD, Beck RW, Simon JH,. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000; 343: 898-904.
-
(2000)
N Engl J Med
, vol.343
, pp. 898-904
-
-
Jacobs, L.D.1
Beck, R.W.2
Simon, J.H.3
-
23
-
-
0021035886
-
Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
-
Kurtzke JF., Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
-
24
-
-
78650860714
-
Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis
-
Balashov KE, Aung LL, Vaknin-Dembinsky A,. Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis. Ann Neurol 2010; 68: 899-906.
-
(2010)
Ann Neurol
, vol.68
, pp. 899-906
-
-
Balashov, K.E.1
Aung, L.L.2
Vaknin-Dembinsky, A.3
-
25
-
-
0028809507
-
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions
-
Windhagen A, Newcombe J, Dangond F,. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995; 182: 1985-1996.
-
(1995)
J Exp Med
, vol.182
, pp. 1985-1996
-
-
Windhagen, A.1
Newcombe, J.2
Dangond, F.3
-
26
-
-
0030996263
-
Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease
-
Svenningsson A, Dotevall L, Stemme S,. Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease. J Neuroimmunol 1997; 75: 59-68.
-
(1997)
J Neuroimmunol
, vol.75
, pp. 59-68
-
-
Svenningsson, A.1
Dotevall, L.2
Stemme, S.3
-
27
-
-
0027403299
-
The role of the CD28 receptor during T cell responses to antigen
-
Linsley PS, Ledbetter JA., The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191-212.
-
(1993)
Annu Rev Immunol
, vol.11
, pp. 191-212
-
-
Linsley, P.S.1
Ledbetter, J.A.2
-
28
-
-
0027284230
-
Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation
-
Gimmi CD, Freeman GJ, Gribben JG,. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci U S A 1993; 90: 6586-6590.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, pp. 6586-6590
-
-
Gimmi, C.D.1
Freeman, G.J.2
Gribben, J.G.3
-
29
-
-
0028949152
-
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
-
Kuchroo VK, Das MP, Brown JA,. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995; 80: 707-718.
-
(1995)
Cell
, vol.80
, pp. 707-718
-
-
Kuchroo, V.K.1
Das, M.P.2
Brown, J.A.3
-
30
-
-
0037438358
-
Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo
-
Lumsden JM, Williams JA, Hodes RJ., Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J Immunol 2003; 170: 781-787.
-
(2003)
J Immunol
, vol.170
, pp. 781-787
-
-
Lumsden, J.M.1
Williams, J.A.2
Hodes, R.J.3
-
31
-
-
77954154971
-
Downregulation of Dicer enhances tumor cell proliferation and invasion
-
Han L, Zhang A, Zhou X,. Downregulation of Dicer enhances tumor cell proliferation and invasion. Int J Oncol 2010; 37: 299-305.
-
(2010)
Int J Oncol
, vol.37
, pp. 299-305
-
-
Han, L.1
Zhang, A.2
Zhou, X.3
-
32
-
-
0034749944
-
Matrix metalloproteinases: Multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis
-
Leppert D, Lindberg RL, Kappos L,. Matrix metalloproteinases: Multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001; 36: 249-257.
-
(2001)
Brain Res Brain Res Rev
, vol.36
, pp. 249-257
-
-
Leppert, D.1
Lindberg, R.L.2
Kappos, L.3
-
33
-
-
77953694905
-
Lineage-specific transcriptional regulation of DICER by MITF in melanocytes
-
Levy C, Khaled M, Robinson KC,. Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell 2010; 141: 994-1005.
-
(2010)
Cell
, vol.141
, pp. 994-1005
-
-
Levy, C.1
Khaled, M.2
Robinson, K.C.3
|